We are live on ! Find out more
EOLS icon

Evolus

56 hedge funds and large institutions have $98.6M invested in Evolus in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 13

37% more funds holding

Funds holding: 41 → 56 (+15)

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

3.94% less ownership

Funds ownership: 18.85% → 14.9% (-3.9%)

29% less capital inflows, than outflows

Capital inflows: $10.3M | Capital outflows: $14.5M

Holders
56
Holders Change
+15
Holders Change %
+36.59%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
13
Reduced
10
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

EOLS Hedge Fund Activity: Q2 2018 in Review

56 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q2 2018, worth a combined $98.6M — up 146% from $40.1M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new EOLS positions and 13 closed out — a net gain of 15 holders — while 13 added to existing stakes and 10 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $3.13M. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $4.52M sold.

  • 56 institutional investors held Evolus (EOLS) as of Q2 2018, up from 41 in Q1 2018.
  • Funds reported $98.6M of Evolus stock for Q2 2018, up 146% quarter-over-quarter.
  • 28 funds opened new Evolus positions in Q2 2018 and 13 closed out, a net change of +15 holders.
  • The largest Evolus buyer in Q2 2018 was Morgan Stanley, an estimated $3.13M added.
  • The largest Evolus seller in Q2 2018 was Schroder Investment Management Group, an estimated $4.52M sold.

Based on aggregated 13F filings for Q2 2018.